Antibiotic Stewardship Monitoring Not Completed
Summary
The facility failed to implement its antibiotic stewardship program by not ensuring monitoring for adverse effects and appropriate antibiotic use for three residents receiving antibiotics. The report identified deficiencies involving Resident 35, Resident 7, and Resident 101, each of whom had antibiotic orders and care plan interventions that required monitoring for side effects and documentation of resident response. Facility policies required licensed staff to observe residents for side effects, signs of antibiotic resistance or secondary infections, and to document reactions, interventions, and provider notification in the EHR. For Resident 35, the record showed orders for cephalexin and fluconazole for infection prophylaxis related to a right lower leg wound and urinary tract/vaginitis prophylaxis. The MDS Coordinator stated the indication for fluconazole did not specify what infection was being prevented and that monitoring for adverse effects on cephalexin and fluconazole was incomplete. The resident’s care plan and the facility’s antibiotic stewardship and adverse reaction policies required observation for side effects and documentation, but the record review and interview showed this monitoring was not completed as expected. For Resident 7, the record showed orders for ertapenem for infection and Zyvox for pneumonia, with the care plan directing staff to monitor and document side effects and effectiveness every shift and report adverse reactions as needed. The MDS Coordinator stated monitoring for adverse effects on ertapenem and Zyvox was incomplete. The facility’s policies and the drug information reviewed for these antibiotics identified the need to observe for allergic reactions, diarrhea, blood pressure changes, seizures, and other adverse effects, but the documentation reviewed did not show that this monitoring was completed. For Resident 101, the record showed cephalexin for cellulitis of the left elbow and later levofloxacin for infection of the left elbow and increased WBC. The Infection Preventionist and MDS Coordinator stated the resident did not meet the criteria for cephalexin or levofloxacin based on the surveillance forms and available lab data, and that the physician should have been notified. The MDS Coordinator also stated there was no documentation that the resident was monitored for adverse side effects on multiple shifts during the antibiotic courses. The DON stated residents on antibiotic therapy were supposed to be monitored every shift for the duration of therapy plus three days and documented in progress notes, but that did not occur for this resident.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.